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increased number of inflammatory and immunolabelled cells for IL-6 were 
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and MTAP than the GC (p<0.001) at 7 days; after 30 and 60 days, no 
significant differences were observed among TSC, MTAP and CG (p=0.955). 
The number of immunolabelled cells for IL-6 was similar for TSC, MTAP and 
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Statement of Clinical Relevance 
 
 The evaluation of inflammatory response induced by experimental tricalcium 
silicate cement with 20% zirconium oxide and MTA Plus showed similar 
subcutaneous reaction in rats, suggesting that they are biocompatible to be used 
as reparative materials. 
 
 
*Statement of Clinical Relevance (max 40 words)
HIGHLIGHTS 
 
 Inflammatory response induced by experimental tricalcium silicate cement with 
20% zirconium oxide and MTA Plus was evaluated.  
 A gradual decrease was observed in the number of the inflammatory and IL-6-
immunopositive cells. 
  Tricalcium silicate repair materials caused similar subcutaneous and immune 
responses in rats, suggesting that they are biocompatible. 
 The tricalcium silicate cements may be use as reparative materials. 
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Tissue response and immunoexpression of IL-6 promoted by tricalcium silicate-
based repair materials after subcutaneous implantation in rats 
 
 
Abstract 
The aim of the present study was to evaluate the inflammatory response induced by 
experimental tricalcium silicate cement with 20% zirconium oxide (TSC) and MTA 
Plus (MTAP) in rat subcutaneous tissues.  Polyethylene tubes were filled with TSC (n = 
20) and MTAP (n = 20), and implanted in the dorsal subcutaneous tissues of thirty two 
rats. Empty tubes were used as control (CG; n = 20). After 7, 15, 30 and 60 days, the 
tubes with connective tissue were removed and the inflammatory cells (IC) and 
immunolabelled cells for interleukin-6 (IL-6) were counted. Data were statistically 
analyzed by ANOVA and the Tukey tests (p≤0.05). An increased number of 
inflammatory and immunolabelled cells for IL-6 were observed at 7 days. The number 
of inflammatory cells was higher for TSC and MTAP than the GC (p<0.001) at 7 days; 
after 30 and 60 days, no significant differences were observed among TSC, MTAP and 
CG (p=0.955). The number of immunolabelled cells for IL-6 was similar for TSC, 
MTAP and CG at all evaluated periods. A gradual and significant decrease was 
observed in the number of IC and IL-6-immunopositive cells. At 60 days, the capsules 
adjacent to TSC and MTAP exhibited fibroblasts and bundles of collagen fibers. The 
TSC and MTAP caused similar subcutaneous reaction in rats, suggesting that they are 
biocompatible and present similar immune responses.  
 
Key Words:  Tricalcium Silicate, Zirconium Oxide, Biocompatibility, 
Immunohistochemistry, Interleukin-6.  
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Introduction 
Mineral Trioxide Aggregate (MTA) is a tricalcium silicate-based cement, with 
bismuth oxide (Bi2O3) as radiopacifier (1). Tricalcium silicate-based biomaterials have 
demonstrated proper biological and physicochemical properties (2-5). The replacement 
of Bi2O3 by other radiopacifers has been proposed (6-8), since Bi2O3 interferes in the 
hydration of MTA (9), resulting in an increase in porosity and reduction of material 
strength (10). Furthermore, bismuth oxide interferes in cellular proliferation (11) and 
calcium silicate-based materials containing Bi2O3 induce inflammatory response in rat 
subcutaneous tissue (12). 
Another disadvantage of some MTA materials is the presence of Portland 
cement as major component, which may contain heavy metal contamination (13). MTA 
Plus (MTAP) (Avalon Biomed Inc., Bradenton, FL, USA) is composed of tricalcium 
silicate and dicalcium silicate added to Bi2O3 (14). As a material used in the 
pulpotomies, MTAP produced calcium hydroxide and did not exhibit dental 
discoloration (15). Moreover, MTAP promoted low immunoexpression of interleukin-
1β and -1α, inflammatory cytokines, and allowed mineralized tissue formation over the 
pulp tissue of rats (16). Gomes-Cornélio et al. demonstrated that MTAP presents 
biocompatibility and bioactivity in human osteoblast-like cells (17).  
A manufactured tricalcium silicate cement [(CaO)3.SiO2, Mineral Research 
Processing, Meyzieu, France], associated with zirconium oxide (ZrO2) as a radiopacifier 
is used as reparative material (18). The association of 80% pure tricalcium silicate 
(TSC) and 20% ZrO2 presents proper properties, such as, solubility, radiopacity, 
compressive strength, setting time and microhardness (3). Furthermore, this cement in 
contact with simulated tissue fluid demonstrated bioactivity (3,19). Despite these, until 
now, there is no other evidence of the biological in vivo response of this material 
reported in the literature. 
The aim of the present study was to evaluate the tissue response promoted by 
TSC and MTAP in rat subcutaneous tissues. Morphological and morphometric analyses 
and the immunohistochemical reaction for detection of interleukin-6, a pro-
inflammatory cytokine, were performed. The null hypothesis was that there would be no 
difference in tissue reactions caused by TSC and MTAP. 
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Material and methods 
The present research protocol was analyzed and approved by the Ethical 
Committee for Animal Research of Araraquara Dental School, UNESP, Brazil (Process 
CEUA No. 33/2014). 
In this study thirty two rats were used, distributed into three groups: TSC 
(Tricalcium silicate, Mineral Research Processing, Meyzieu, France, and 20% ZrO2, 
Sigma Chemicals, St Louis, Missouri, USA), MTAP (MTA Plus
TM
 Avalon Biomed 
Inc., Bradenton, Florida, USA) and CG (Control Group; empty polyethylene tubes). The 
composition and proportion of the materials evaluated are described in Table 1.  
After anesthesia with 80 mg/kg ketamine chloride 10% (Virbac do Brasil 
Indústria e Comércio Ltda, São Paulo, São Paulo, Brazil) and 8 mg/kg xylazine  
chloride  2% (União Química Farmacêutica Nacional S/A, São Paulo, São Paulo, 
Brazil),  administered by intraperitoneal route, dorsal skin was shaved and disinfected 
with 5% iodine solution. A 2 cm incision was made with a nº15 scalpel blade (Fibra 
Cirúrgica, Joinville, Santa Catarina, Brazil). Afterwards, polyethylene tubes (Embramed 
Indústria e Comércio Ltda., São Paulo, São Paulo, Brasil), measuring 10 mm long x 1.5 
mm in diameter, were filled with TSC or MTAP and immediately implanted into the 
subcutaneous tissue. The site of the incised skin was sutured with simple stitches using 
4-0 silk thread (Ethicon Inc., São José dos Campos, São Paulo, Brazil). Two polythene 
tubes was used in each animal; 5 animals per group were used in each time point. 
After 7, 15, 30 and 60 days of implantation, the animals were euthanized with 
anesthetic overdose, and the implants with the surrounding tissues were removed. The 
specimens were immediately immersed in a formaldehyde 4% solution (prepared from 
paraformaldehyde) buffered with sodium phosphate 0.1 M with pH 7.2, for 48 hours. 
After fixation, the specimens were dehydrated, treated with the xylene and embedded in 
paraffin. Longitudinal sections (6 µm thick) were obtained and were stained with 
hematoxylin and eosin (HE) for morphological analysis and quantification of 
inflammatory cells in the capsules. Other sections were adhered to slides previously 
treated with silane 4% (Sigma-Aldrich Co., Saint Louis, Missouri, USA), to  perform 
the immunohistochemical reaction for interleukin-6 (IL-6) detection. 
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Numerical density of inflammatory cells 
The images were obtained with a digital camera (DP-71, Olympus, Tokyo, 
Japan) attached to a light microscope (BX-51, Olympus, Tokyo, Japan).  
The number of inflammatory cells (IC) was quantified using an image analysis 
system (Image Pro-Express 6.0, Olympus), as previously described (12). The 
quantitative analysis was performed in all samples or implants; in each implant, three 
HE-stained sections of the capsule were used at intervals of at least 100 µm. In each 
section, a standardized field of 0.09 mm
2
 of the capsule in close juxtaposition to the 
opening of implanted tube was captured totalling 0.27 mm
2
 per implant. In each field, 
the number of IC (neutrophils, lymphocytes, plasma cells and macrophages) was 
computed. In this way, in each implant, the number of IC/mm
2
 was obtained. The 
numerical density of inflammatory cells was measured by two calibrated and blinded 
examiners. 
 
Immunohistochemical reaction for detection of IL-6  
For IL-6 detection, the primary goat antibody anti-IL-6 (Santa Cruz 
Biotechnology Inc., Santa Cruz, California, USA) was used. Deparaffinized sections 
were immersed in 0.001 M sodium citrate buffer with pH 6.0, and submitted to 
microwave oven cycles for 20 minutes at 90-94ºC for antigen retrieval. After cooling, 
the slides were washed in 0.05 M Tris-HCl buffer with pH 7.4, and subsequently 
immersed in 5% hydrogen peroxide for 20 minutes, for blocking endogenous 
peroxidase. After washing, the sections were incubated with 2% bovine serum albumin 
(Sigma-Aldrich Co., Saint Louis, Missouri, USA), for 20 minutes. Sections were 
incubated overnight in a humid chamber at 4°C with anti-IL-6 antibody, diluted 1:100. 
Subsequent to washing in Tris-HCl buffer, the sections were incubated for 40 
minutes at room temperature with a multi-link solution containing biotinylated 
rabbit/mouse/goat antibodies (LSAB, Dako Inc., Carpinteria, California, USA). After 
washing in Tris-HCl buffer, the sections were incubated with HRP complex (System-
HRP, Dako Inc., Carpinteria, California, USA), for 40 minutes at room temperature. 
Subsequent to washing in buffer, peroxidase activity was revealed by the chromogen 
3.3-diaminobenzidine-HCl (DAB, Dako Inc., Carpinteria, California, USA) for 3 
minutes. The sections were counterstained with Carazzi’s hematoxylin. As negative 
control, some sections were submitted to all the stages, except incubation with primary 
antibody; in this step the sections were incubated in non-immune serum.  
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Numerical Density of cells positive for IL-6 
With the purpose of verifying whether there were differences among the groups, 
the number of IL-6-immunolabeled cells was estimated in the capsules of the 5 implants 
of each group/time point. As previously described, the Image Pro-Express 6.0 Olympus 
software was used. The numerical density of IL-6-immunolabeled cells was obtained by 
two calibrated and blinded examiners. For each animal, the number of immunolabeled 
cells was quantified at x695, in a standardized field (0.09 mm
2
) of the capsule in close 
juxtaposition to the opening of the implanted tube. Thus, the number of IL-6 
immunolabeled/mm
2
 per animal was obtained (8,12). 
 
Statistical Analysis  
The quantitative data were submitted to statistical analysis by using the Sigma 
Stat 2.0 program (Jandel Scientific, Sausalito, California, USA). After normality was 
confirmed, the two-way ANOVA and Tukey tests were used, at a level of significance 
of 5%. 
 
Results 
Morphological and numerical density analysis of inflammatory cells  
At 7 days, the capsules in all the groups exhibited several inflammatory cells, 
mainly lymphocytes and macrophages among the blood vessels (Figs. 1A-1C). At 15 
days, the capsules contained fibroblasts and collagen fibers, particularly in TSC and 
CG. However, inflammatory cells and blood vessels were still clearly observed in the 
capsules (Figs. 1D and 1F). Occasionally, some multinucleated giant cells were also 
observed, mainly in the internal portion of the capsules, adjacent to the materials (Fig. 
1D). After 30 and 60 days, the connective tissue of the capsules contained several 
fibroblasts between the collagen fiber bundles; the scarce inflammatory cells were 
represented by plasma cells, macrophages and mast cells (Figs. 2A-2F). 
Quantitative analysis revealed that in all the groups, the number of inflammatory 
cells was significantly higher at 7 days. After this period, the statistical analysis of each 
group revealed a gradual and significant reduction in the number of inflammatory cells 
in the capsules of all groups (p<0.001) over time. At 7 days, no significant differences 
were verified between TSC and MTAP (p=0.592), however, these values were 
statistically higher in comparison with those of the control group (p<0.001). In turn, in 
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the periods of 30 and 60 days, no significant differences were observed among TSC, 
MTAP and control group (p=0.955) (Table 2). 
 
Immunohistochemical detection of IL-6 and numerical density of immunopositive cells  
The sections of capsules submitted to the immunohistochemical reaction for IL-
6 showed inflammatory cells (lymphocytes, plasma cells, macrophages and mast cells) 
and some fibroblasts exhibiting positivity to immunoreaction. Morphological analysis 
revealed immunolabeled cells in the capsules of all the groups; however, an accentuated 
immunopositivity was observed in the capsules at 7 days in comparison with the other 
periods (Figure 3). On the other hand, sections of capsules incubated without the 
primary antibody (negative control) exhibited no immunopositive cells (data not 
illustrated).  
According to Table 2, the number of IL-6-immunolabeled cells was significantly 
higher at 7 days than at 15, 30 and 60 days. In all the groups, the number of 
immunolabeled cells was significantly reduced from 7 to 60 days. However, no 
statistically significant differences were detected among TSC, MTAP and CG, in any of 
the periods. 
 
Discussion 
Histopathological analysis of the subcutaneous response after different 
experimental periods evaluate not only the tissue characteristics to irritant potential but 
also the duration of this effect on tissues (5,20,21).  
The present study showed that the TSC and MTAP induced an inflammatory 
reaction in the subcutaneous tissues. However, this reaction was gradually reduced, 
leading to the formation of dense connective tissue in the capsules. The reduction in the 
inflammatory reaction occurred concomitantly with the reduction in the 
immunoexpression of IL-6 in the capsules adjacent to the materials, indicating that the 
experimental TSC cement and MTAP are biocompatible materials. The inflammatory 
reaction initially caused by TSC and MTAP may be related to the hydroxyls (OH
-
) 
released after hydration of the materials, providing an environment with an alkaline pH 
(3,14,18). The alkaline pH stimulates recruitment of the leukocytes of the blood vessels 
(8,12,22,23) and therefore, may explain the higher values of inflammatory cells verified 
in the initial time point. 
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The tissue reaction observed is a consequence of the host response to substances 
released by the materials. Therefore, the host cells (inflammatory and resident) produce 
and release several cytokines and growth factors that play a specific role in the complex 
cascade of cellular events involved in the tissue response. Among the different 
cytokines, IL-6 is considered a powerful mediator of the inflammatory process (24).  
An association has been observed between the reduction in immunoexpression 
of IL-6 and a reduction in the inflammatory process in the capsules adjacent to the 
calcium silicate-based cements implanted in the rat subcutaneous tissues (8,12), 
indicating that these materials do not have an irritating effect on connective tissue 
during a prolonged period.  
The gradual and significant reduction in the number of immunolabeled cells for 
IL-6 suggests that the capsules adjacent to the materials implanted undergo an intense 
remodeling process from 7 to 60 days. Moreover, our results point out that this cytokine 
may be involved in the response promoted by tricalcium silicate-based materials, 
because a reduction in both immunolabeled cells for IL-6 and in the number of 
inflammatory cells was observed. Considering that no significant differences in the IL-6 
immunoexpression was observed for TSC and MTAP compared with the control group, 
it is possible to suggest low irritant potential of the materials to the tissues. In spite of 
this, materials promoted a greater recruitment of inflammatory cells than the empty 
tube. Therefore, these materials may release some substances that stimulate the 
migration and differentiation of cells, such as macrophages and plasma cells, frequently 
observed in the capsules at 7 days. However, the inflammatory process was replaced by 
a capsule containing well-developed bundles of collagen fibers between fibroblasts at 
30 and 60 days after implantation. This tissue response indicates that the materials are 
biocompatible. 
It has been demonstrated that ZrO2 added to calcium silicate cement promotes 
adequate physicochemical properties and a better biologic response than Bi2O3 (12). 
Nevertheless, in the present study, MTAP which presents Bi2O3 promoted a 
subcutaneous tissue response similar to that of TSC. The hypothesis for this finding 
may be related to the fact that MTAP does not have Portland cement in its composition 
but instead it has tricalcium silicate (approximately 50%), dicalcium silicate, calcium 
sulphate and silicon dioxide in addition to Bi2O3 (approximately 30%). The substitution 
of Portland cement by tricalcium silicate and dicalcium silicate allows better control of 
heavy metals that are found in the MTA (18), favoring the hydration reaction (3). 
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Conclusion 
The TSC and MTAP caused similar subcutaneous implantation reaction in rats, 
indicating that both present similar immune response. The significant reduction in the 
inflammatory reaction accompanied by decrease in the IL-6 immunoexpression in the 
capsules over time indicates that these tricalcium silicate-based materials may have 
potential as root repair material.  
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Figure legends: 
Figure 1 – Light micrographs of sections showing portions of capsules adjacent to the 
opening of the tubes implanted (T) in the subcutaneous tissue after 7 (Figs. 1A-1C) and 
15 (Figs. 1D-1F) days. In Figs. 1A, 1B and 1C, several inflammatory cells (arrows) are 
observed, mainly, in the portion of the capsule adjacent to the opening of the tubes (T). 
N, neutrophil; Bv, blood vessels. Figs. 1D, 1E and 1F, exhibit inflammatory cells 
(arrows) among blood vessels (Bv) and fibroblasts (Fb). Gc, giant cells. HE. 695x.  
 
Figure 2 – Light micrographs of sections showing portions of capsules adjacent to the 
opening of the tubes implanted (T) in the subcutaneous tissue after 30 (Figs. 2A-2C) 
and 60 (Figs. 2D-2F) days. Typical fibroblasts (Fb) are observed among bundles of 
collagen fibers (Cf) in the capsules.Few inflammatory cells (arrows) are present, mainly 
in the capsules of MTAP and control group. Mp, macrophages; P, plasma cells; M, mast 
cells; Bv, blood vessels. HE. 695x. 
 
Figure 3 – Light micrographs of sections showing portions of capsules adjacent to the 
opening of the tubes (T) implanted in the subcutaneous tissue after 7 (Figs. 3A-3C), 15 
(Figs. 3D-3F), 30 (Figs. 3G-3I) and 60 (Figs. 3J-3L) days of implantation. Sections 
were submitted to immunohistochemistry reaction for IL-6 detection and counterstained 
with haematoxylin. Several immunolabeled cells (arrows; brown/yellow colour), 
especially, plasma cells, mast cells and some fibroblasts (Fb) are observed in the 
capsules at 7 and 15 days. At 60 days, scarce cells exhibit immunolabelling for IL-6. 
Bv, blood vessels. 500x. 
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Tables: 
Table 1 – Materials evaluated and used proportions. 
Group Material Composition Proportion 
(powder/distilled 
water) 
 
TSC 
 
 
Cement tricalcium 
silicate* with 20% ZrO2** 
 
 
Tricalcium silicate, 
Zirconium oxide 
 
1g/ 340 µL   
 
MTAP 
 
White Mineral Trioxide 
Aggregate*** 
 
 
Tricalcium Silicate, 
Dicalcium Silicate, Calcium 
Sulphate, Silica, Bismuth 
Oxide 
 
 
1g/ 340 µL 
 
* Mineral Research Processing, Meyzieu, France 
** Sigma Chemicals, St Louis, Missouri, USA 
*** MTA Plus
TM
 Avalon Biomed Inc., Bradenton, Florida, USA 
 
 
Table 2 – Numerical density of inflammatory cells (IC) and IL-6 immunolabeled cells 
in the capsules of TSC, MTAP e control groups at 7, 15, 30 and 60 days. 
 
 TSC MTAP control 
7 days 
IC 
IL-6 
 
482.5 (45.9)
b,1
 
475.5
 
(16.4)
a,1
 
 
448.8 (34.8)
b,1
 
480.0
 
(14.4)
a,1
 
 
    324.0
 
(29.9)
a,1
 
    464.4
 
(19.8)
a,1
 
15 days 
IC 
IL-6 
 
 185.1
 
(28.2)
ab,2
 
186.6
 
(18.2)
a,2
 
 
214.8
 
(43.6)
b,2
 
      195.5
 
(12.6)
a,2
 
 
    154.0
 
(8.1)
a,2
 
    182.2
 
(12.6)
a,2
 
30 days 
IC 
IL-6 
 
160.0
 
(30.3)
a,2
 
   148.8
 
(18.5)
a,3
 
 
135.5
 
(29.0)
a,3
 
      151.1
 
(14.9)
a,3
 
 
    148.8
 
(8.0)
a,2
 
    144.4
 
(17.5)
a,3
 
60 days 
IC 
IL-6 
 
71.1
 
(9.5)
a,3
 
75.9
 
(8.9)
a,4
 
 
70.3
 
(16.1)
a,4
 
       75.5
 
(9.3)
a,4
 
 
      69.0
 
(6.5)
a,3
 
      71.1
 
(9.9)
a,4
 
*mean (standard deviation) The comparison amongst groups (p<0.05) is indicated by 
different superscript (a, b, c and d) in the various lines. 
The comparison amongst periods (p<0.05) is indicated by number superscripts in the 
various columns. 
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Figure 1
Click here to download high resolution image
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Author's Point-by-Point Response to Reviewers 
 
Reviewers' comments: 
 
Reviewer #1:  
Introduction 
1. Paragraph 1. Reference 7 not applicable here; join with reference 9 instead? 
A: Reference 7 (Camilleri et al., 2011) is related to a study of some characteristics, such 
as, microstructure and pH, of Portland cement with zirconium oxide. The authors stated 
that zirconium oxide is inert and can be used as a substitute of bismuth oxide. On the 
other hand, reference 9 (Camilleri 2007) evaluate the hydration mechanisms of calcium 
silicate materials with bismuth oxide. That is why we used the reference in the text. 
 
2. Paragraph 2. Line 24. Change to, "as a material used in pulpotomies...". Line 31: 
move the reference (17) to the end of the sentence. 
A: The corrections were performed in the text. 
 
3. Paragraph 3. Line 36. Change to, "as a radiopacifier...". Line 45: change to, "There 
is no other evidence of the biological in vivo response of this material reported in the 
literature." 
A: The corrections were performed in the text. 
 
4. Paragraph 4. Line 48. Remove "thus"; remove since this method determined...". Line 
55 change to " ...there would be no difference..." 
A: The corrections were performed in the text. 
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Material and Methods 
1. Paragraph 3. Why not use an unbranded, monofilament suture to decrease 
inflammatory response. 
A: We really appreciate the suggestion and it will considered for futures studies. 
However, incision was performed in the centre of dorsal subcutaneous and the pockets, 
where tubes were implanted, were performed at a distance of 10 mm. Based in the 
histological images, we believe that the inflammatory response caused by the incision 
and its healing process does not interfere with the tissue reaction of the materials. 
 
2. Immunohistochemical reaction for detection of IL-6: Paragraph 2. Line 60. "In this 
step the sections were incubated in non-immune...?" 
A: We have made the correction. 
 
Discussion. 
1. Paragraph 5. Lines 35-42. Consider shortening this into 2-3 sentences instead of one. 
General rule is that shorter sentences allow for better reading comprehension. 
A: We have made the corrections 
 
References. 
1. Recommendations as stated above. 
A: We have made the corrections. 
 
Legends. 
1. Add "tissue" after "subcutaneous". 
A: We have made the corrections. 
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